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Background
Mutations in proteins can have deleterious effects on a protein’s stability and function, which ultimately
causes particular diseases. Genetically inherited muscular dystrophies include several genetic diseases, which
cause increasing weakness in muscles and disability to perform muscular functions progressively. Different
neuro-muscular diseases are caused by different types of mutations in the gene coding. Mutations in genes
make defunct proteins or none at all. Defunct or missing protein interactions in human proteome may cause a
stress to its neighboring proteins and subsequently to modules it is involved in. Network biology is utilized to
gain knowledgeable insights on system properties of complex protein-protein interaction maps governing affected
cellular machinery due to disease causing mutations. We therefore aimed to understand the effects of mutated
proteins on interacting partners in different muscular dystrophies.
Results
We investigated rigidity and flexibility of protein-protein interaction subnetworks associated with causative
mutated genes showing high mean interference values in muscular dystrophy. Rigid component related to
Eukaryotic Translation Elongation Factor 1 Alpha 1 (EEF1A1) subnetwork and members of 14.3.3 protein
family formed the core of network showed involvement in molecular function related to protein domain specific
binding. Core nodes of core modules showed high modular overlapping and bridgeness values. The subnetworks
showing highest flexibility comprised of seed nodes Calcium channel, voltage-dependent, L type, alpha 1S subunit
(CACNA1S) and calmodulin 1 (CALM1) showing functionality related to Voltage-dependent calcium channel.
The interconnected subnet of proteins corresponding to known causative genes having large genetic variants are
shared in different Muscular dystrophies (MDs) inferred towards comorbidity in diseases.
Conclusion
The studies demonstrates core network of MDs as highly rigid component constituting of large intermodular
edges and interconnected hub nodes suggesting high information transfer flow.The core skeleton of the network
are organized in protein binding and protein specific domain binding.This suggests neuro-muscular disorders may
initiate due to interruption in molecular function related with the core and its aggression may depend on the
tolerance level of the networks.
3Introduction
Neuro-muscular diseases, such as muscular dystrophies (MDs), are associated with muscle weakness, muscle
atrophy and a progressive cardiac dysfunction over time. Any muscle can be affected by this condition,
however it is most prominent in limb-girdle and proximal muscle groups with varied involvement of distal
muscles [1]. Myopathies in effect for a long period may produce loss of absolute volume of muscle and
these conditions are associated with muscle wasting [2]. Genetically heterogeneous MDs range from severe
to benign forms such as Ducchene to Limb girdle muscular dystrophy (mild). Mitochondrial abnormalities
are associated with ocular myopathies, whereas metabolic disorders are involved in the acquired chronic
inflammatory myopathies dermatomyositis and polymyositis [1].
Most diseases are caused by mutations in more than one gene which can either be dominant or recessive.
In MDs, Such dominant and recessive pathological defects are shared by a subset of genes involved in diverse
mechanisms related to muscle degeneration and weakness. Such mechanisms orchestrate many intricate and
common biological pathways [3]. Biological pathways consist of a set of dependent actions carrying out a
specific function. They take place in cells among molecules such as proteins, metabolites and enzymes. A
particular function can be hampered if one or more components of a biological pathway fail to perform.
Damaging mutations in proteins can be considered as one of such cases, aborting their functionality and
related pathways. Missense mutations in muscular dystrophies are often associated with neuro-muscular
abnormalities and cognitive impairment [4, 5].
Biological networks
Multiple biological pathways lack boundaries, often are interconnected, and work together to accomplish
tasks. The interconnected component of biological pathways is called a biological network. Networks are
valuable prototypes for analyzing the complexity in cellular environments and the interactions, which influ-
ence the normal functionality of the cells.
Biological networks exhibit modular organization dependent on functions. Modules are sets of nodes
that share many edges, and are loosely connected to the rest of the network, representing densely associated
entities. Core nodes of a module have large number of edges to other proteins within modules and are
essential to its functions. Modules exhibit fuzzy boundaries and are interconnected to perform wide variety of
functions in cells. Perturbed components in a network, such as in the case of mutated proteins, can influence
the coherent overlapping modules in human proteome [6]. Proteins linking different modules together are
important for inter-modular communications and show high bridgeness values [7]. Modules in protein-protein
interaction networks of yeast partially disintegrate upon stress, removing important inter modular edges,
thus preventing flow of information [8]. Moreover, if a module contains proteins with unknown function, the
functional characterization may help in determining functional prediction of those proteins. [9, 10].
Better understanding of structural functional aspects can be studied taking dynamics of networks into
account, along with network topology. The latter provides understanding of network architecture. Biological
networks show non random degree distribution and small world property. Non random degree distribution
also known as scale-free degree distribution, in which large number of nodes have fewer edges and few nodes
having many edges are known as hub nodes. Their targeted deletion disrupts the network structure [11,12].
Hub proteins serve as common edges and mediate short path lengths between other edges. Shortest path
4length is a distance between two nodes and median of the means of the shortest path lengths connecting each
nodes to all other vertices is known as characteristic path length. Small world networks, in which any two
nodes in the networks can be connected with short paths, exhibit smaller diameter, small characteristic path
length, and high clustering coefficient [13]. Clustering coefficient ranges from 0 to 1, and provides a measure
of the degree to which nodes tend to cluster in network [7]. Betweenness centrality is the number of shortest
paths from all vertices to all others that pass through that node. It measures traffic loads through one
node as information flows over a network primarily following the shortest available paths. High betweenness
centrality proteins behaves as a bottlenecks in protein-protein interaction networks. Bottleneck proteins
regulate most of the informational flow, hence indicates the essentiality of proteins [14, 15]. Clique is a set
of nodes which have all possible ties among themselves. A maximal clique is a clique that is not contained
in any other clique.
Propagation, rigidity and flexibility in networks
The diseased state can be characterized as a malformed propagation state among constituting modules.
Dynamics of modules from rigid to flexible state depend upon the environmental cues and the internal
structure of the networks. Removal of protein or protein complexes may significantly alter the network,
affecting flow of information, efficiency and adaptability. Adaptability is associated with flexibility of the
networks, whereas rigidity is associated with the memory [16]. Rigidity and flexibility can be assessed
by combinatorial graph theory and it is described by degrees of freedom and number of over-constraints
associated with the nodes in the network [17].
Our approach
In this article, we focused on (i) assessing the snapshot of dynamics of network propagation and interference
from pairs of hub and essential mutated proteins causative in different neuro-muscular disorders; (ii) evalu-
ating rigidity and flexibility (tolerance level) in protein-protein interaction networks of the most interfered
sub-networks in muscular dystrophies. (iii) determining the modular organization and, (iv) characterizing
molecular function of modules.
A systematic characterization of MDs has to take into account the overlap of different traits and the
heterogeneity of cellular processes for many of the genes involved. The analysis and classification of multiple
genes and their mutations is still challenging in terms of cost and time, even with the advent of sequencing
technologies [18]. The proposed strategies overcomes the limits of existing solutions which compare protein-
protein interaction networks of disease and control states, solely on topological characteristics. We are able
to predict which sub-networks are more rigid in presence of such mutations. To best of our knowledge, we
investigated for the first time, the rigidity and flexibility issues in sub-networks of human proteome.
Methods
The neuro-muscular diseases are broadly classified in 13 groups based on previous studies [19]. We construct
the protein interaction map of causative genes involved in the disease using a dataset by Center for Biomedical
Computing at University of Verona [20]. The dataset is extracted from various databases storing high
5throughput methods and experimentally known interactions [21–24], and it is manually curated and updated.
Information on disease causing variants is downloaded from Leiden Open Variant Database [25]. Networks
are visualized using Cytoscape and Gephi [26, 27]. Network layout is performed using force directed graph
drawing [28]. Centrality measure of nodes, which gives relative importance of nodes within a network,
are calculated using Netanalyzer [12, 29] and in-house R and python scripts. Hub and key proteins of the
interconnected seed network are computed using degree distribution, betweenness centrality (BC), maximal
clique centrality (MCC), and bottleneck nodes [30].
Network propagation
The interference is the measure of overlapping flow among nodes [31]. It is obtained visiting each node
by random walks initiating at different sources. Larger interference implies wider overlap between flows
originating from different sources and small interference signifies little overlap. The emitting model is
obtained using qmbpmn-tools [32], which is initiated with every possible pair of proteins in the first order
network, to compute mean interference and maximum visits.
Module detection and functional characterization
ModuLand framework analyzes the overlapping modules in networks using bridgeness and overlapping values.
It uses Proportion Hill module membership assignment method and NodeLand influence function algorithm
[33,34]. In ModuLand framework, modularity of a network is computed by determining community centrality
by summing up influence zones containing a given edge. Overlapping modules are identified on the basis
of hills on community centrality landscape, and each node of the network is assigned to the module with
different strength [33, 34]. Overlap values for nodes demonstrates the effective number of modules to which
they are assigned, and bridgeness values are high, if nodes show larger overlap between many module pairs.
Modules are named after the core node of the module. BiNGO plug-in is used for functional characterization
of the modules [35]. Molecular function is assigned on consensus basis to the modules based on p-values and
involvement on core nodes from top ten core nodes in the molecular function.
Rigidity and flexibility
Rigidity and flexibility issues were previously studies at a structural level of proteins through various method-
ologies [36–39]. We investigated the properties characterizing different states such as rigidity and flexibility
of a complex system upon perturbation. Rigidity and flexibilty for subnetworks showing maximum interfer-
ence values and first order network are analyzed using pebble game algorithm in KINARI-lib [17, 40]. The
pebble game algorithm computes total number of degrees of freedom and overconstrained regions in a graph.
This algorithm requires sparsity parameters (k, l) on protein-protein interaction networks to be analyzed.
Pebble game algorithm on 2D bar joint framework is guaranteed for rigidity to all (k, l)-sparse graphs for
k and l such that l ∈ (0, 2k). Initially, k pebbles are posed on each vertex with no edges and then one of
pebbles is displaced from i after adding an edge ij towards j, if at least l + 1 pebbles are between vertices
l and j. In continuation to this, ij is reversed and pebble is moved from j to l, if pebble is on j and ij
edge exists in pebble game’s graph. Any subset of n′ vertices spans at most kn′− l vertices in (k, l) graph is
6called sparse whereas it is called as tight or rigid if it has n vertices and kn− l edges [41–43]. We compute
the index (overconstraints - degree of freedom) divided by average degree of subnetwork to avoid size bias
of the network in calculation of DOF’s and over-constrained regions. High positive values obtained for the
subnetwork are associated to high rigidity, and negative values with flexibility. This is based on the fact that
higher degrees of freedom represent higher flexibility while higher over-constrained regions or nodes indicate
rigidity of the network.
Results
Network Topology
There are 206 proteins affected by causative mutations in genes responsible for MDs, which are experimentally
known to show protein-protein interaction. Such proteins form an interconnected component (seed network)
of the protein-protein interaction map composed of 137 nodes and 307 edges. The first order network
obtained from the 206 proteins is composed of 4076 proteins and 133847 edges. Both networks satisfy scale
free property, following the power law in degree distribution [11]. Scale free property infer the robustness of
such networks against random failures of the nodes (Figure 1). The seed network has a clustering coefficient
of 0.28 whereas first order network forms clusters with clustering coefficient 0.33. The small characteristic
path length of 3.95 and 2.53 for interconnected seed network and first order network respectively shows
average efficiency of transmission of information in network in less than 4 steps. Essential and hub nodes
in the interconnected component is calculated using centrality statistics, which gives measure of load and
linkedness of the nodes [Table 1]. Large number of genetic variants are associated with hub proteins and
essential nodes (Supplementary Table S1)
Table 1: Key and Hub nodes computed based on centrality statistics: Degree, Betweenness Centrality,
Bottleneck and Maximal Clique Centrality. The key nodes in bold are considered on consensus basis if
occurred at least twice in detection.
Degree Betweenness Bottleneck Maximal Clique
Centrality Centrality
TTN DAG1 TTN TTN
TPM1 TTN DAG1 DES
LMNA VCL ACTA1 TPM1
ACTN2 ACTA1 TPM1 LMNA
DES LAMA2 HSPB1 MYLK2
ACTA1 PGK1 LAMA2 ACTN2
FLNA FLNA FLNA MYL3
HSPB1 ITGA7 PGK1 MYH7
VCL DMD ITGA7 CACNA1S
MYLK2 TPM VCL MYH2
7Figure 1: (A) Modular organization of giant component of protein-protein interaction network of seed
mutated nodes in different muscular dystrophies. (B) Average clustering Coefficient distribution of nodes
(C) Degree distribution of proteins in networks. (D) First order network of 206 proteins showing causative
mutations (E) Average clustering coefficient distribution of proteins (F) Degree distrubution of proteins in
first order network.
Functional characterization
The interconnected seed network is modularly organized around five overlapping modules. Hub node TTN
formed core module of the seed network with molecular function related to structural molecule activity
8(p = 3.9E− 7, GO-id 5198), along with calmodulin binding (p = 2.8E− 5, GO-id 5516). Module SGCA and
Module SGCG are involved in calcium ion binding (p = 5.9E−4 and p = 4.3E−4, GO-id 5509), respectively,
which is known to be involved in diseased state of Sarcoglycanopathies [44]. Module GYG1 is involved in
catalytic activity such as transferase activity (p = 2.2E−4, GO-id 16740). Module GARS comprises of only
3 proteins with functionality related to ligase activity (p = 6.9E − 3, GO-id 16874). All those modules are
depicted in (Figure 1(A)). Nineteen overlapping modules characterize the first order network on consensus
basis with function related to protein, DNA binding, transferase activity and structural molecule activity
(Table 2). The top ten core nodes governing the modular function is listed in (Supplementary Table S2). The
interconnected hub nodes constitutes the core skeleton of the first order network as well as central module
EEF1A1.(Supplementary Figure S1).
Figure 2: Relationship between disease and proteins corresponding to causative mutated genes. Red nodes
are diseases and Grey − > blue is low to high value of genetic variants.
9Protein-disease association
The interaction map of formed by the seed mutated proteins and the thirteen neuro-muscular diseases
is composed of 268 nodes with 285 edges. Disconnected components of the network relate to congenital
myasthenic syndromes,linked with 13 proteins. The giant meta-network of the remaining twelve neuro-
muscular disorders comprise 262 nodes and 270 edges. The network in (Figure 2) depicts proteins showing
higher genetic variants shared by many different muscular diseases. Congenital myopathies and limb girdle
dystrophies, dominant (LGD, dominant) share numerous interacting partners with congenital myopathies
and hereditary cardiomyopathies. LMNA protein shows involvement in four different muscular dystrophic
diseases. The DMD protein connected with large number of interacting partners in first order protein
interaction map, it has highest genetic variants, and it is specifically linked to muscular dystrophy and
hereditary cardiomyopathies in protein-disease interaction map (Figure 2). It is already very well known
fact that cardiac disease is a clinical manifestation related to muscular dystrophies. [45].
Network propagation from key pair of causative proteins in muscular dystrophies
Modules exhibit fuzzy boundaries as discussed earlier and it is therefore hard to understand the rigidity
and flexibility associated with them. In order to understand the rigidity and flexibility associated with the
modules, we compute the interference (flow overlap) on first order network from pair of key proteins of seed
network listed in (Table 1). The network propagation initiating from these nodes is obtained with the using
emitting model of qmbpmn-tools, which calculates interference in the first order network (Supplementary
Table S3). From the top forty proteins showing maximum interference from each pair of mutated proteins.
We then ranked them on quartiles of the computed mean interference. In (Table 3), proteins with high
bridgeness in the network (>1) are shown as receiving interference.
Maximum number of visits producing highest mean interference value is observed in the core node
YWHAZ, present in 3 different modules and responsible for molecular function related to protein domain
specific binding (p = 4.0E − 06, GO-id 19904). The other proteins with mean interference greater than
quartile percentage of 90 [see Supplementary Table S4] and large number of visits show diverse functionality
ranging from localization (p = 4.6E − 2, GO-id 51179) to cellular component organization (p = 2.3E − 2,
GO-id 16043) and intracellular transport (p = 4.6E − 2, GO-id 46907). CACNA1S receives largest mean
interference value from the single duplet of DES/TPM1, which shows involvement in voltage gated calcium
channel activity and skeletal muscle adaptation (p = 3.8E − 2, GO-id 43501). DES/TPM1 proteins are
functional in structural constituent of cytoskeleton (p = 1.8E − 3, GO-id 5200).
Rigidity and flexibility in protein protein interaction networks
We focus on assessing network rigidity and flexibility issues and determine the tolerance level of the sub-
networks of the proteins showing maximum interference. Extracted subnetworks show heterogeneity and
varying clustering coefficient ranging from 0.531 to 0.994 with varied clustering pattern of proteins. [Sup-
plementary table S5]. This provide an overview on the global network, and the possibility to determine
which subnetwork is susceptible to affect the functionality of the modules. KINARI-lib computed The rigid-
ity/flexibility for whole network for k = 2 and l = 3 showing 24509 degrees of freedom and 130751 over
10
constraints. Variable rigidity/flexibility in subnetworks shed light on varied tolerance level in structural and
functional integrity based on degrees of freedom and over constraints [Figure 3].
Figure 3: Showing ratio of DOF (Degree of Freedom) and average degree, overconstraints and average
degree and difference of DOF and overconstraints with respect to average degree to overcome size bias of
the network k = 2 and l = 3 for the subnetworks of nodes listed in Table 1 which showed mean interference
values calculated from emitting model of ITMprobe. Positive values in green line indicate rigidity and negative
values indicate flexibility. Higher the positive value higher the network is rigid and vice versa.
Subnetwork of core node eukaryotic translational factor 1 alpha (EEF1A1) of core module EEF1A1 shows
rigidity with many folds over-constrained nodes over degrees of freedom. This subnetwork has even higher
constrained nodes as compared with first order network of the seed nodes. This module function is related
to protein binding (p = 2.6E − 02).
The rigid sub networks corresponding to 14-3-3 proteins family, which binds to functionally diverse sig-
naling proteins, are also rigid components of the network. The 14.3.3 family protein subnetworks (YWHAE,
YWHAG, YWHAZ and YWHAQ) consitituting the core nodes of module Heat Shock 70kDa Protein 8
(HSPA8) in this network share many interacting partners. The rigidity results for over-contrained regions
over degree of freedoms in subnetworks are consistent for all possible value analyzed, and for all the possible
combination of k = 1, . . . , 6 and l = 1, . . . , 6. (Supplementary Figure S2). The CACNA1S and CALM1
sub-networks demonstrate maximum flexibility with minimum over-constraints with nodes. With respect to
degrees of freedom, they show involvement in functionality related voltage-gated calcium channel activity
(p = 2.2E − 02, GO–id 5245) and calcium ion binding (p = 2.9E − 3, GO-id 5509). The flexibility in
this subnetworks indicates functional flexibility of calcium, that is known to have various functions in our
body and countering external influences for proper functioning in cellular environment calcium synergists
are needed.
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Discussion
The rigidity and flexibility issues in networks are much less studied in context of biological networks. Biolog-
ical networks have modular organization [46] without proper boundaries therefore, it is hard to understand
the tolerance level of different overlapping modules and their molecular function of the protein-protein inter-
action networks. In this article, our focus on rigidity and flexibility analysis on protein-protein interaction
subnetworks after detection of interference values from pair of key causative agents.
Seed protein-protein interaction map and first order neighbors
The seed network and first order network shows robustness and small world behavior. Lower clustering
coefficient shows sparsity in interaction map as compared with cancer, aging subnetwork in human pro-
teome [47]. Essential and hub proteins in seed network computed using various centrality measures such as
linkedness of nodes, shortest path traversing through nodes, key connector proteins and maximally connected
subgraphs demonstrates high number of genetic variants corresponding to the proteins (see Supplementary
Table S1). LMNA protein,a hub protein linked with 4 different neuro-muscular diseases. In our work, we
found that LMNA protein receives interference from different pairs and also emits maximum interference
to hub nodes at first order network when paired with other mutated proteins (see additional material 1).
LMNA is suggested to play a role in nuclear stability, chromatin structure and gene expression [48]. This
infers towards the epigenetic regulation in progression of diseases by gene expression coordination in regu-
lating different genes and subsequently to proteins in first order interactions as well as indirect interactions.
Large number of proteins with high genetic variants shared different neuro-muscular diseases which indicated
towards co-morbidity in MDs. Hub proteins with high genetic variants are positioned at central position and
can possess lethal characteristics in diseased state of muscular dystrophies [12]. This lethality can disrupt
the functionality of cells. Interconnected hub proteins of robust and small world first order MDs network
displays high betweenness centrality values which indicates these proteins as maximum load bearing nodes in
the network forming the core skeleton of the network. Core nodes of central module EEF1A1 constitutes of
the same interconnected hubs, which suggests faster information flow at the core skeleton of network. Muscle
interactome in Saccharomyces cerevisiae and Caenorhabditis elegans shows higher informational flow [49].
Network propagation from essential and hub proteins from seed network demonstrates highly central proteins
receiving mean interference and visits from different pair of complexes.
Structural integrity in protein-protein interaction networks
Rigidity index in twelve subnetworks of the proteins that received large mean interference value (q> 90)shows
variability. The subnetworks constituting core module and core skeleton of first order networks shows highest
rigidity. In details,our studies demonstrate the subnetwork of interconnected neighbors of EEF1A1 having
hub property and core proteins of core module in first order network demonstrates the maximum rigidity.
EEF1A1 Subnetwork demonstrated rigidity more than the parent network. Perturbing this subnetwork will
largely affect the module EEF1A1 and other closely interconnected modules. This is because of the fact
that we found most of the proteins showing high bridgeness value, which gives account of inter-modular
links constitutes this module. It is highly evident that this module is providing rigidity to the subnetwork
of Human proteome related to muscular disorders.
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In functional aspect, it is known that quality of muscles are affected by age and gender [50] and the core
node of this module is evidenced as core node of the core module of the Sirt family protein-protein interaction
network, which is widely known to be implicated in aging related processes. However, Sirt7, a member of
Sirt protein family, also showed mean interference and visits from the mutated complexes (Supplementary
Table S3). Sirt family of proteins also provides functionality related to muscle development [47]. Hormone
replacement therapy is used for preserving muscle strength [51] and EEF1A1 module is associated with
muscle degeneration with progression of age. Core node ESR1 (estrogen receptor alpha) of EEF1A1 module
is involved in menopausal processes and therefore the muscle weakening in the women also emphasizes on
this fact.
The subnetworks of closely related 14.3.3 family protein YWHAE, YWHAG, YWHAZ, YWHAQ show
rigidity and share large number of interacting partners, hence suggesting low tolerance level. Overall as-
sessment of the rigidity in protein protein interaction network of the MDs evidenced towards core of the
network being highly rigid with proteins having large number of visits from different mutated pairs. The
perturbation in any member of 14.3.3. family subnetworks may influence connected modules and the other
protein family members.
Identification of genetic alterations that cause clinical phenotypes, such as severity of diseased states
and mutations especially somatic are typically very diverse in neuro-muscular disorders. These are found
in different subsets of genes in different patients [52]. The complexity grows with the heterogeneity of the
mutations and their associations between individual mutations and a clinical phenotype. Driver mutations
are observed to contribute to cancer development [53]. Mutations driving neuro-muscular disorders may also
target genes in cellular pathways and can influence first and second order interacting partners. Identification
of driver nodes using network perspective [54] will provide more knowledgeable insights on dynamics of
tolerance level in different modules of networks.
Functional integrity
Modular function related to core module of protein binding and protein domain specific binding is indis-
pensable in MDs. Muscular dystrophies are largely known to be associated with inability in specific domain
interactions in proteins [55]. Network modular organization resulted in functionality related to protein
binding and structure molecule activity, which emphasizes on the fact that network is functionally inclined
towards the specific binding of cytoskeletal protein complexes to enhance structural integrity of the assembly
of interacting partners. Essential protein for protein synthesis EEF1A1 showed decline in protein abundance
in wasted mutant mice leading to muscle wasting, motor neuron loss and immune system abnormalities [56].
The mutations in proteins can be considered as non functional entity in the network and thus considered
as deleted which in a way can drive network towards homogeneity. Targeted or random deletion of nodes
enhances homogeneity in network [57]. This homogeneity in network can proliferate the processes in unidi-
rectional way. In other aspects of protein-protein interaction networks, modules become dysfunctional due
to failure of key protein or simultaneously many proteins fail to perform function as in the case of mutations.
Other modules or proteins have to share the burden of these modules or proteins or lack thereof. Hence it
will be of interest to understand co-operativity issues related to driver mutations in network to which extent
modules misses to perform functionality and which modules become performs functions to which extent.
13
Conclusions
In conclusion, PPI’s analysis not only reveals important characteristics and underlying behaviors, such
as key interfered candidates but also tolerance level of networks and molecular mechanisms in muscular
dystrophy. Hub nodes with large genetic variants involves in different neuro- muscular diseases suggesting
comorbidity. Rigidity in networks is associated with the interconnected hubs in first order network. The
core of the network faster informational flow with high betweenness value in interconnected hubs. Functional
rigidity in neuromuscular diseases is associated with protein binding and domain specific binding. This
suggests muscular dystrophies may initiate due to failure of specific binding of the proteins which ultimately
can affect interacting proteins responsible for different molecular function such as cytoskeletal remodelling,
protein folding and degradation, cell signalling modulation.
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Table 3: The mean interference on the nodes originated from the duplets identified on the consensus basis
on topological characteristics. The proteins in bold font show higher bridgeness value (greater than 1). q1
is the first quartile, q2 is the median and q3 is the third quartile.
Proteins with mean Proteins with mean Proteins with mean Proteins with mean
interference ≤ q1 interference in (q1, q2] interference in (q2, q3] interference > q3
ACTN1 ACTA1 ALB ACTA2
AHCYL1 ATP5B CBL ACTG1
ATM BRCA1 CDK1 ACTN2
BGN CAND1 CDK2 ACTN3
CAV1 COPS5 CTNNB1 ATP5A1
CSK DNAJA1 F7 CALM1
DDB1 EGFR FN1 CEP250
DRP2 HSP90AB1 HNRNPA2B1 ESR1
GCN1L1 HSPB1 HSP90AA1 H1F0
ITGB1 JUN HSPA8 HIST1H2AG
KRT6A KRT14 HSPA9 HIST1H2BD
LAMA1 KRT5 ITGA4 HNRNPC
LAMA5 MYC KIAA0101 HNRNPM
MAP2 PRKCA KRT8 KRT18
NCSTN RUVBL2 MYL12A MYH2
PRX SFN NONO MYH9
PSEN1 SPTAN1 PXN MYL3
SGCA TPM3 SIRT7 TSC2
SHC1 TUBB TIAM1 VIM
SNTA1 UBR5 TPM1 YWHAE
TSC22D1 VCAM1 UBD YWHAH
VCL XRCC5 YWHAZ
WWP1
WWP2
YWHAB
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List of abbreviations used
Abbreviations Full name
BC Betweenness centrality
CACNA1S Calcium channel, voltage-dependent, L type, alpha 1S subunit
CALM1 Calmodulin
DMD Dystrophin
DNA Deoxyribonucleic acid
EEF1A1 Eukaryotic Translation Elongation Factor 1 Alpha 1
ESR1 Estrogen receptor alpha
GARS Glycyl-tRNA synthetase
GO-id Gene Ontology ID
GYG1 Glycogenin 1
LGD, dominant Limb girdle dystrophies, dominant
LMNA Lamin A/C
MCC Maximal clique centrality
MDs Muscular dystrophies
PPI’s Protein-protein interaction
SGCA Sarcoglycan, alpha (35kDa dystrophin-associated glycoprotein
SGCG Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein
TTN Titin
YWHAE Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein,
epsilon polypeptide
YWHAG Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein,
gamma polypeptide
YWHAQ Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein,
theta polypeptide
YWHAZ Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein,
zeta polypeptide
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Supplementary Figures
Figure S1: Interconnected high degree proteins (hub nodes) in first order network. Size of the node corre-
sponds to the linkedness of the node.
Figure S2: Rigidity and flexibility analysis obtained from Kinari-LIB for all possible combination of k = 1
and l = 1 until k = 6 and l = 6 for the subnetworks of nodes listed in table 2 which showed largest mean
interference values calculated from emitting model of ITM Probe.
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Supplementary Tables
Table S1: Genetic variants associated causative genes of neuro-muscular diseases downloaded from Leiden
Open Variant Database
Name Number of variants Name Number of variants Name Number of variants
ACTA1 378 GAN 6 PLEC 67
ACTC1 142 GARS 107 PLEKHG5 0
AGRN 32 GDAP1 0 PMP22 2
ANKRD1 170 GFPT1 75 POMGNT1 244
ANO5 336 GJB1 0 POMT1 396
ARHGEF10 14 GK 176 POMT2 156
ASAH1 19 GMPPB 27 PRPS1 0
ATL1 13 GNB4 11 PRX 0
B3GALNT2 28 GNE 741 PTRF 42
B3GNT1 26 GTDC2 14 RAB7A 8
BAG3 20 HSPB1 0 RAPSN 1008
BANF1 38 HSPB3 0 RYR1 2116
BIN1 70 HSPB8 0 SBF2 0
BSCL2 0 IGHMBP2 172 SEPN1 1301
CAPN3 2831 IKBKAP 0 SEPT9 0
CAV3 467 ISCU 72 SETX 12
CCDC78 5 ISPD 101 SGCA 753
CCT5 13 ITGA7 179 SGCB 354
CFL2 44 KBTBD13 59 SGCD 525
CHAT 102 KIF1B 0 SGCE 323
CHKB 37 KLHL40 56 SGCG 966
CHRNA1 208 LAMA2 1503 SGCZ 16
CHRNB1 198 LAMP2 97 SH3TC2 0
CHRND 194 LARGE 63 SLC12A6 0
CHRNE 418 LDB3 101 SMCHD1 95
CNTN1 8 LITAF 0 SMN1 542
COL6A1 313 LMNA 3850 SOX10 0
COL6A2 278 MATR3 123 SPTLC1 0
COL6A3 364 MFN2 2 SPTLC2 0
COLQ 211 MICU1 23 SSPN 16
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Table S1: Genetic variants associated causative genes of neuro-muscular diseases downloaded from Leiden
Open Variant Database. (Table continued)
Name Number of variants Name Number of variants Name Number of variants
CRYAB 95 MPZ 2 SYNE1 163
CTDP1 0 MSTN 312 SYNE2 7
DAG1 134 MTM1 529 TCAP 75
DCTN1 0 MTMR14 36 TMEM5 36
DES 305 MTMR2 0 TNNI2 61
DMD 25828 MUSK 139 TNNI3 0
DMD d 9235 MYBPC3 3 TNNT1 28
DNAJB6 81 MYH7 4 TNNT2 1145
DNM2 130 MYL2 80 TNNT3 17
DOK7 501 MYL3 74 TNPO3 65
DPM3 5 MYOT 140 TPM1 177
DTNA 1 MYOZ1 11 TPM2 517
DUX4 159 MYOZ2 39 TPM3 78
DYSF 2292 MYOZ3 19 TRAPPC11 8
EGR2 0 MYPN 1474 TRDN 12
EMD 222 NDRG1 0 TRIM32 123
FAM134B 0 NEB 243 TTN 3686
FGD4 0 NEFL 3 TTR 0
FHL1 70 NGF 0 VCP 161
FIG4 0 NTRK1 724 VMA21 49
FKRP 1007 PABPN1 520 WNK1 0
FKTN 577 PDK3 26 YARS 0
FLNC 39 PDLIM3 21 ZMPSTE24 1745
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Table S2: Top core nodes of the overlapping modules detected by ModuLand framework
Module 1 Module 2 Module 3 Module 4 Module 5 Module 6 Module 7
EEF1A1 CUL3 ATM PRPF4 RBM8A SNRPF KRT1
SUMO2 SUMO2 DDB1 LSM2 UPF3B SNRPE KRT14
ELAVL1 COPS5 TTN CSTF1 CDC40 SNRPD2 KRT5
FN1 CAND1 GCN1L1 SNRNP40 APP FN1 KRT6A
ESR1 CUL1 DICER1 TXNL4A NFX1 YWHAZ KRT10
KIAA0101 ELAVL1 DCD FN1 FN1 ELAVL1 CDCP1
CUL1 FN1 KRT10 APP ELAVL1 CDK2 KRT9
APP APP RANBP2 CUL3 SF3A2 ITGA4 ATM
YWHAZ ESR1 KRT9 ELAVL1 NUP153 CUL2 CBL
SUMO1 HSPA5 KRT5 DDX23 SF3A3 CUL1 GRB2
Module 8 Module 9 Module 10 Module 11 Module 12 Module 13 Module 14
SMN1 HSPA8 PCNA CSNK2A1 MEPCE HSP90AA1 RAC1
DDX20 YWHAE S100A8 SART1 PRPF31 CDK1 GDI2
UBR5 HSP90AA1 HDAC1 NUP188 CSNK2A1 PLK1 RHOA
CALM1 YWHAQ BRCA1 NUP93 PARP1 SRC ECT2
PLK1 YWHAG HDAC2 PARP1 CSNK2B EGFR VAV2
HSPA9 YWHAZ TP53 MEPCE PLS3 PTK2 ITSN1
RAN YWHAH RAN CSNK2B PIN1 TUBB RHOD
PSMA3 CDK1 HSPB1 PRPF31 NUP93 CDK2 KALRN
HSPD1 TUBB MDC1 PIN1 GFM1 MAPK1 RHOG
MYC PLK1 MYC PLS3 MRPS16 PTK2B RAC2
Module 15 Module 16 Module 17 Module 18 Module 19
ATP5A1 NDUFA9 NDUFS2 KRT85 FOXK1
ATP5B NDUFA10 NDUFA5 KRT31 FOXK2
ATP5C1 NDUFB4 IDH3A KRT33B MPP7
APP ATP5J2 DLD KRT34 SCLT1
MDH2 CYCS OGDH KRT81 DYNLL2
IKBKE UQCRH NDUFV2 ADSL LONP2
CDK2 NDUFB9 NDUFS3 USP15 LIN7A
SLC25A5 NDUFS6 NDUFB6 LGALS7 NIN
SRC UQCRFS1 NDUFS4 LRRC15 BAG3
CYCS UQCRB SUCLG2 PGAM2 MPP5
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Table S3: Number of times proteins received interference and the mean inference of the node.
Protein Number of duplets Mean Protein Number of duplets Mean
that affect this protein interference that affect this protein interference
YWHAZ 54 0.03 ITGA4 9 0.02
ACTB 50 0.02 LARGE 9 0.01
HSP90AA1 50 0.02 NCSTN 9 0.01
MYH9 47 0.02 PRX 9 0
YWHAG 47 0.02 VCAM1 9 0.02
YWHAQ 47 0.02 CAV3 8 0.01
YWHAE 46 0.02 DRP2 8 0
APP 44 0.02 MYH13 8 0.02
SUMO2 44 0.02 MYL3 8 0.02
VIM 44 0.02 EGFR 7 0.02
CALM1 43 0.02 HSPD1 7 0.01
ELAVL1 43 0.02 LAMA1 7 0
YWHAH 43 0.02 LAMA5 7 0.01
ESR1 42 0.02 DES 6 0.02
CBL 41 0.02 HIST1H2BD 6 0.02
EEF1A1 41 0.02 KRT1 6 0.02
ATP5A1 39 0.02 MYH2 6 0.02
HNRNPC 39 0.02 ACTN3 5 0.02
RPS3 39 0.02 CDK1 5 0.02
ACTG1 38 0.02 H1F0 5 0.02
FN1 38 0.02 RALY 5 0.02
CUL3 37 0.02 SDHB 5 0
TTN 30 0.02 TPM3 5 0.02
HNRNPA2B1 28 0.02 COPS5 4 0.02
MYL12A 28 0.02 KRT10 4 0.02
H2AFX 27 0.02 PXN 4 0.02
TUBB2A 27 0.02 YWHAB 4 0.01
KRT8 25 0.02 ACTC1 3 0.02
CDK2 22 0.02 ALB 3 0.02
HSPA5 22 0.02 FLNA 3 0.02
KIAA0101 22 0.02 HIST1H1D 3 0.02
KRT17 22 0.02 HSPB1 3 0.01
GRB2 21 0.02 KRT9 3 0.02
MYH11 21 0.02 MAP2 3 0
ACTA2 20 0.02 NONO 3 0.02
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Table S3: Number of times proteins received interference and the mean inference of the node. (Table
continued)
Protein Number of duplets Mean Protein Number of duplets Mean
that affect this protein interference that affect this protein interference
HSPA8 20 0.02 ACTA1 2 0.02
TP53 20 0.02 ACTN4 2 0.01
KRT18 19 0.02 CAND1 2 0.02
CEP250 18 0.02 DDB1 2 0.01
TSC2 18 0.02 GAPDH 2 0.02
HIST1H1C 17 0.02 GCN1L1 2 0.01
HSPA9 17 0.02 HNRNPM 2 0.02
SRC 17 0.02 POLR2E 2 0.02
TUBA1A 17 0.02 S100A8 2 0.02
VCP 17 0.02 SPTAN1 2 0.01
ACTN1 15 0.01 TIAM1 2 0.02
CUL1 15 0.02 UBD 2 0.02
LMNA 15 0.02 XPO1 2 0.02
PTK2 14 0.01 XRCC5 2 0.02
SUMO1 13 0.02 AHCYL1 1 0.01
TUBB 13 0.02 ATM 1 0.01
VCL 13 0.01 ATP5B 1 0.02
ACTN2 12 0.02 BRCA1 1 0.02
CAV1 12 0.01 CACNA1S 1 0.03
CSK 12 0.01 CTNNB1 1 0.02
DMD 12 0.01 DHX9 1 0.01
FYN 12 0.02 DICER1 1 0.01
ITGB1 12 0.01 DNAJA1 1 0.02
MYC 12 0.02 F7 1 0.02
MYH7 12 0.02 HSPA1L 1 0.02
NCK1 12 0.01 JUN 1 0.01
PIK3R1 12 0.01 KRT14 1 0.01
SHC1 12 0.01 KRT5 1 0.01
SIRT7 12 0.02 KRT6A 1 0.01
TLN1 12 0.01 MAGI1 1 0
TPM1 12 0.02 MYLK2 1 0.02
UTRN 12 0.01 NCL 1 0.02
HIST1H2AG 11 0.02 NCOA3 1 0.01
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Table S3: Number of times proteins received interference and the mean inference of the node. (Table
continued)
Protein Number of duplets Mean Protein Number of duplets Mean
that affect this protein interference that affect this protein interference
HSPG2 11 0.01 PABPC1 1 0.01
PRKDC 11 0.02 PRKCA 1 0.01
PSEN1 11 0.01 RAC1 1 0.02
SGCA 11 0.01 RUVBL2 1 0.02
SH3KBP1 11 0.01 SFN 1 0.01
SNTA1 11 0.01 TSC22D1 1 0.01
VASP 11 0.02 UBR5 1 0.02
BGN 9 0.01 WWP1 1 0
HSP90AB1 9 0.02 WWP2 1 0
31
Table S4: Proteins in first order network with maximum mean interference values from pairs of key proteins
known as causative agents in muscular dystrophy.
Proteins with mean interference > q90 Number of duplets affecting the protein Mean interference
YWHAZ 54 0.026
ACRB 50 0.024
MYH9 47 0.022
YWHAG 47 0.021
YWHAQ 47 0.021
YWHAE 46 0.021
CALM1 43 0.021
EEF1A1 41 0.02
ACTG1 38 0.02
CEP250 18 0.02
MYH13 8 0.021
MYH2 6 0.023
ACTN3 5 0.022
POLR2E 2 0.02
CACNA1S 1 0.025
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